Luke F Western, Giovanni Diana, Prav Praveen, Michael W Ho, Jagtar Dhanda, David Tighe, Conor Bowe, Adam Holden, Gaurav Barsaiyan, Jeremy McMahon, Walid El Kininy, Stergios N Doumas
{"title":"侧化T3/T4N0口腔鳞状细胞癌。是否需要对侧选择性颈部清扫或颈部放疗?一项多中心回顾性研究。","authors":"Luke F Western, Giovanni Diana, Prav Praveen, Michael W Ho, Jagtar Dhanda, David Tighe, Conor Bowe, Adam Holden, Gaurav Barsaiyan, Jeremy McMahon, Walid El Kininy, Stergios N Doumas","doi":"10.1016/j.bjoms.2025.04.007","DOIUrl":null,"url":null,"abstract":"<p><p>Oral squamous cell carcinoma (OSCC) is a prevalent malignancy with a propensity for lymphatic spread, particularly to the neck. There are current inconsistencies in the treatment paradigm for cT3/4 OSCC with negative nodal status. The American Society of Clinical Oncology (ASCO) recent guidelines advocate for contralateral neck treatment with neck dissection or radiotherapy, but this approach remains debated and has not been adopted within UK clinical guidance. This study aims to evaluate the recurrence rates and survival outcomes of patients with well lateralised pT3/4N0 OSCC managed with or without contralateral neck interventions. A retrospective cohort study was conducted across five UK Oral and Maxillofacial Surgery (OMFS) units. We included patients with biopsy-proven pT3/T4 OSCC treated between 2012 and 2017. The study compared outcomes between two groups: the standard care group (SC) and the extended neck management group (ENM), which additionally received contralateral neck dissection (CLND) or neck radiotherapy (NRT). The primary outcome measure was the recurrence rate (RR), with secondary outcome measures including overall survival (OS), disease-free survival (DFS) and recurrence-free survival (RFS). Of 583 patients, 210 met the inclusion criteria. The mean follow up was 44 months. The SC group, compared with ENM demonstrated similar overall recurrence rate (24.8% vs 24.6%), higher regional recurrence (7.4% vs. 1.6%) and lower distant recurrence rates (4% vs 6.6%) respectively, however, none of these results reached significance. No significant differences in OS, DFS, or RFS were demonstrated (p > 0.05) between groups, and this was maintained with confounding variables controlled for. Findings suggest that well lateralised T3/4N0 OSCC patients managed more conservatively, without contralateral neck intervention, may have comparable outcomes to those receiving additional neck management. Further research into this area of research paucity may assist in further refinement of management guidelines for this subset of OSCC patients.</p>","PeriodicalId":55318,"journal":{"name":"British Journal of Oral & Maxillofacial Surgery","volume":" ","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Lateralised T3/T4N0 oral squamous cell carcinoma. Is contralateral elective neck dissection or neck radiotherapy indicated? A multicentre retrospective study.\",\"authors\":\"Luke F Western, Giovanni Diana, Prav Praveen, Michael W Ho, Jagtar Dhanda, David Tighe, Conor Bowe, Adam Holden, Gaurav Barsaiyan, Jeremy McMahon, Walid El Kininy, Stergios N Doumas\",\"doi\":\"10.1016/j.bjoms.2025.04.007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Oral squamous cell carcinoma (OSCC) is a prevalent malignancy with a propensity for lymphatic spread, particularly to the neck. There are current inconsistencies in the treatment paradigm for cT3/4 OSCC with negative nodal status. The American Society of Clinical Oncology (ASCO) recent guidelines advocate for contralateral neck treatment with neck dissection or radiotherapy, but this approach remains debated and has not been adopted within UK clinical guidance. This study aims to evaluate the recurrence rates and survival outcomes of patients with well lateralised pT3/4N0 OSCC managed with or without contralateral neck interventions. A retrospective cohort study was conducted across five UK Oral and Maxillofacial Surgery (OMFS) units. We included patients with biopsy-proven pT3/T4 OSCC treated between 2012 and 2017. The study compared outcomes between two groups: the standard care group (SC) and the extended neck management group (ENM), which additionally received contralateral neck dissection (CLND) or neck radiotherapy (NRT). The primary outcome measure was the recurrence rate (RR), with secondary outcome measures including overall survival (OS), disease-free survival (DFS) and recurrence-free survival (RFS). Of 583 patients, 210 met the inclusion criteria. The mean follow up was 44 months. The SC group, compared with ENM demonstrated similar overall recurrence rate (24.8% vs 24.6%), higher regional recurrence (7.4% vs. 1.6%) and lower distant recurrence rates (4% vs 6.6%) respectively, however, none of these results reached significance. No significant differences in OS, DFS, or RFS were demonstrated (p > 0.05) between groups, and this was maintained with confounding variables controlled for. Findings suggest that well lateralised T3/4N0 OSCC patients managed more conservatively, without contralateral neck intervention, may have comparable outcomes to those receiving additional neck management. Further research into this area of research paucity may assist in further refinement of management guidelines for this subset of OSCC patients.</p>\",\"PeriodicalId\":55318,\"journal\":{\"name\":\"British Journal of Oral & Maxillofacial Surgery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-06-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British Journal of Oral & Maxillofacial Surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.bjoms.2025.04.007\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"DENTISTRY, ORAL SURGERY & MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Oral & Maxillofacial Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.bjoms.2025.04.007","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
引用次数: 0
摘要
口腔鳞状细胞癌(OSCC)是一种常见的恶性肿瘤,有淋巴扩散的倾向,尤其是颈部。目前对阴性淋巴结状态的cT3/4型OSCC的治疗模式存在不一致性。美国临床肿瘤学会(ASCO)最近的指南提倡对侧颈部进行颈部解剖或放疗治疗,但这种方法仍存在争议,尚未被英国临床指南采用。本研究旨在评估采用或不采用对侧颈部干预治疗的pT3/4N0侧侧良好的OSCC患者的复发率和生存结果。一项回顾性队列研究在五个英国口腔颌面外科(OMFS)单位进行。我们纳入了2012年至2017年间接受活检证实的pT3/T4 OSCC治疗的患者。该研究比较了两组之间的结果:标准护理组(SC)和扩展颈部管理组(ENM),后者额外接受对侧颈部清扫(CLND)或颈部放疗(NRT)。主要结局指标是复发率(RR),次要结局指标包括总生存期(OS)、无病生存期(DFS)和无复发生存期(RFS)。583例患者中,210例符合纳入标准。平均随访时间为44个月。与ENM相比,SC组表现出相似的总复发率(24.8% vs 24.6%),较高的局部复发率(7.4% vs 1.6%)和较低的远处复发率(4% vs 6.6%),但这些结果均不具有显著性。两组间的OS、DFS或RFS无显著差异(p < 0.05),在控制混杂变量的情况下,这一差异得以维持。研究结果表明,对侧位良好的T3/4N0 OSCC患者进行保守治疗,不进行对侧颈部干预,可能与接受额外颈部治疗的患者有相当的结果。对这一领域研究不足的进一步研究可能有助于进一步完善OSCC患者的管理指南。
Lateralised T3/T4N0 oral squamous cell carcinoma. Is contralateral elective neck dissection or neck radiotherapy indicated? A multicentre retrospective study.
Oral squamous cell carcinoma (OSCC) is a prevalent malignancy with a propensity for lymphatic spread, particularly to the neck. There are current inconsistencies in the treatment paradigm for cT3/4 OSCC with negative nodal status. The American Society of Clinical Oncology (ASCO) recent guidelines advocate for contralateral neck treatment with neck dissection or radiotherapy, but this approach remains debated and has not been adopted within UK clinical guidance. This study aims to evaluate the recurrence rates and survival outcomes of patients with well lateralised pT3/4N0 OSCC managed with or without contralateral neck interventions. A retrospective cohort study was conducted across five UK Oral and Maxillofacial Surgery (OMFS) units. We included patients with biopsy-proven pT3/T4 OSCC treated between 2012 and 2017. The study compared outcomes between two groups: the standard care group (SC) and the extended neck management group (ENM), which additionally received contralateral neck dissection (CLND) or neck radiotherapy (NRT). The primary outcome measure was the recurrence rate (RR), with secondary outcome measures including overall survival (OS), disease-free survival (DFS) and recurrence-free survival (RFS). Of 583 patients, 210 met the inclusion criteria. The mean follow up was 44 months. The SC group, compared with ENM demonstrated similar overall recurrence rate (24.8% vs 24.6%), higher regional recurrence (7.4% vs. 1.6%) and lower distant recurrence rates (4% vs 6.6%) respectively, however, none of these results reached significance. No significant differences in OS, DFS, or RFS were demonstrated (p > 0.05) between groups, and this was maintained with confounding variables controlled for. Findings suggest that well lateralised T3/4N0 OSCC patients managed more conservatively, without contralateral neck intervention, may have comparable outcomes to those receiving additional neck management. Further research into this area of research paucity may assist in further refinement of management guidelines for this subset of OSCC patients.
期刊介绍:
Journal of the British Association of Oral and Maxillofacial Surgeons:
• Leading articles on all aspects of surgery in the oro-facial and head and neck region
• One of the largest circulations of any international journal in this field
• Dedicated to enhancing surgical expertise.